News
Shares of Sun Pharma Advanced Research Company (SPARC), the research division of India’s largest pharmaceutical firm Sun Pharma, fell 19 per cent to Rs 158 each after unsatisfactory Phase 2 trial ...
2d
The Crawfish Boxes on MSNAn Update On Astros’ Reliever RegressionAfter the Astros’ bullpen imploded twice in the Rays’ series at Daikin Park, you can be excused if you are wary when the ...
Nvidia's outlook improves with easing tensions and strong fundamentals. Click here to read what warrants a Hold rating for ...
Shares of Gyre Therapeutics declined after the company announced an underwritten public stock offering, undercutting positive trial progress in China for its treatment for liver fibrosis. The stock ...
Lam Research has a long track record of revenue, profit, and share count improvement. Click here to read why we rate LRCX stock a Strong Buy.
Sustaining success is a new thing for the franchise, though. And it's why one reporter believes a natural regression is coming for the Commanders. Bleacher Report writer Moe Moton believes the ...
One of Trump's Cabinet secretaries made an especially well-timed trade of Trump Media stock. Attorney General Pam Bondi sold off her millions of dollars in shares on April 2. That's the same day ...
His replacement has not yet been found. Novo Nordisk stock is down 50% in 12 months, but priced cheaply and growing at nearly 20%. Investors may get a second bite at the apple, and a second chance ...
The stock market plummeted on news of the announcement, depressing the share price of Trump Media. The sale of the shares was expected, and the disclosure form did not include details of the ...
Jay L Clendenin / Getty Images Tesla stock has soared this week on easing U.S.-China tensions. Some market watchers say the stock's rally is setting off alarm bells. Tesla (TSLA) "is flashing ...
FIRST ON FOX: Rep. Mark Alford, R-Mo., on Wednesday will introduce legislation that would ban congressional stock trading, serving as the House companion bill to Sen. Josh Hawley's, R-Mo., ...
Hims & Hers Health shares fell 4.1% Wednesday morning. Despite the pullback, the stock remains up an impressive 116% over the past month. Get access to the leaderboards pointing to tomorrow’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results